Cipla Limited share price

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The…Read more

Website NSE हिंदी में BSE

HealthcareDrug Manufacturers - Specialty & GenericNifty 50 Nifty 100 Nifty 500NSE: CIPLAISIN INE059A01026

16 Oct 2026, 3:29 PM IST₹1,325.10▼ 2.90 (0.22%)

Market Cap₹ 1,07,051 Cr.
Current Price₹ 1,325.10
High / Low₹ 1,673 / 1,166
Stock P/E31.8
Book Value₹ 426
Dividend Yield0.98 %
ROCE14.9 %
ROE11.80 %
Face Value₹ 2.0

More figures (10)

EPS (TTM)₹ 41.70
Price / Book3.11
OPM17.5 %
Debt / Equity0.02
Sales growth (5Y)8.0 %
Profit growth (5Y)10.1 %
Promoter holding31.1 %
EV / EBITDA18.9
Beta0.09
All-time high₹ 1,702

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
CIPLA	-2.42%	-7.30%	+7.69%	-12.32%	-15.57%	+4.40%	+7.96%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Cipla Limited is in the Drug Manufacturers - Specialty & Generic industry (Healthcare), with a market value of ₹1,07,051 crore.
It trades at 31.8 times its last 12 months' earnings and 3.1 times book value.
Revenue grew 8.0% a year over the last 5 years, profit 10.1% a year.
Return on equity was 11.8% and return on capital employed 14.9% in the latest year.
Debt was 0.02 times shareholders' equity.
The share price is 20.8% below its 52-week high and down 15.6% over one year.
Promoters and insiders hold about 31.1%; institutions about 45.0%.

Pros

Company is almost debt-free (debt is 0.02 times equity).
Healthy return on equity of 15.5% on average over the last 3 years.
Institutional (FII + DII) holding has risen by 4.9 points over 3 years.

Cons

Latest quarter (Jun 2026): profit fell 39% from a year ago.
Promoter holding has fallen by 4.26 points over 3 years, to 29.21%.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Cipla Limited

Employees: 31,369
Head office: Mumbai
NSE industry: Healthcare

HealthcareHealthcareDrug Manufacturers - Specialty & Generic

Part ofNifty 50 Nifty 100 Nifty 500

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Cipla	1,325.10	31.8	1,07,051	0.98	786	-39.18	7,119	2.33	14.9	11.8	3.11	17.5	0.02	31.13	28,163	8.0
2.	Sun Pharmaceutical Industries	1,758.80	34.9	4,21,995	0.91	2,895	34.65	15,184	18.48	17.9	14.7	5.05	23.4	0.06	55.61	58,220	10.4
3.	Divi's Laboratories	9,144.50	83.0	2,42,758	0.33	902	36.25	3,080	19.15	19.0	16.2	14.48	28.4	0.00	52.00	10,476	11.0
4.	Torrent Pharmaceuticals	4,558.90	72.8	1,73,406	0.83	566	3.28	4,921	54.85	9.1	27.1	18.39	25.0	1.79	63.18	13,980	13.3
5.	Zydus Lifesciences	1,123.00	25.0	1,12,020	0.09	940	-19.74	7,802	24.03	19.0	19.7	4.17	21.7	0.46	75.18	26,720	16.5
6.	Laurus Labs	2,060.10	101.8	1,11,310	0.12	362	123.94	2,026	29.10	19.5	18.2	20.98	19.4	0.48	32.03	6,813	3.8
7.	Dr. Reddy's Laboratories	1,233.00	31.0	1,02,707	0.66	444	-68.72	8,071	-5.56	14.2	12.1	2.68	14.9	0.21	30.14	33,593	11.0
8.	Aurobindo Pharma	1,666.90	26.0	95,910	0.00	1,033	14.29	9,106	8.65	13.5	9.9	2.56	15.6	0.21	54.79	33,385	10.7
9.	Mankind Pharma	2,275.50	46.0	93,988	0.00	574	29.12	4,031	12.89	13.7	12.5	5.76	19.9	0.39	75.39	14,278	17.7
10.	Lupin	1,961.60	16.2	89,702	0.91	1,415	83.17	8,217	47.73	28.3	26.9	3.99	24.8	0.29	47.02	27,488	19.1
	Median: 50 Co.	1,860.20	31.0	15,877	0.33	844	21.70	7,461	18.81	16.4	13.4	4.02	15.7	0.25	53.40	27,104	12.2

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	6,329	6,678	6,604	6,163	6,694	7,051	7,073	6,730	6,957	7,589	7,074	6,541	7,119
YOY Sales Growth %		14.58%	13.66%	7.39%	5.77%	5.58%	7.10%	9.19%	3.94%	7.64%	0.02%	-2.80%	2.33%
	4,835	4,944	4,856	4,847	4,978	5,165	5,084	5,192	5,179	5,695	5,819	5,586	5,927
Material Cost %	35%	35%	34%	33%	33%	32%	32%	33%	31%	33%	37%	34%	37%
Employee Cost %	17%	16%	16%	18%	18%	17%	17%	18%	19%	17%	19%	22%	21%
Other Expenses %	24%	23%	24%	28%	24%	24%	23%	26%	24%	25%	26%	29%	25%
Operating Profit	1,494	1,734	1,748	1,316	1,716	1,886	1,989	1,538	1,778	1,895	1,255	955	1,192
OPM %	24%	26%	26%	21%	26%	27%	28%	23%	26%	25%	18%	15%	17%
	136	176	185	249	160	191	222	289	259	269	206	148	211
Exceptional items			-195								-276
Interest	16	26	30	18	18	15	15	14	14	13	14	13	17
Depreciation	239	290	233	288	247	272	280	309	253	297	278	383	304
Profit before tax	1,375	1,594	1,474	1,259	1,611	1,789	1,916	1,504	1,770	1,854	893	707	1,082
	28%	27%	28%	26%	27%	27%	17%	19%	27%	27%	24%	22%	27%
Current tax	399	457	330	511	431	459	338	480	530	468	161	282	393
Deferred tax	-21	-18	76	-186	4	24	-5	-201	-52	32	58	-125	-98
	998	1,155	1,068	932	1,175	1,305	1,575	1,214	1,292	1,353	674	543	786
Profit from associates	1	-0	-0	-3	-1	-1	-9	-11	-0	0	-0	-8	-2
Minority share	2	24	13	-7	-2	2	4	-8	-6	2	-2	-12	-4
Profit to shareholders	996	1,131	1,056	939	1,178	1,303	1,571	1,222	1,298	1,351	676	555	789
YOY Profit Growth %		44.89%	32.26%	78.69%	17.77%	12.95%	47.38%	30.29%	9.88%	3.71%	-57.18%	-55.32%	-39.18%
EPS in Rs	12.34	14.01	13.08	11.63	14.58	16.13	19.45	15.13	16.07	16.73	8.37	6.87	9.77
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	4,318	4,665	4,381	4,037	4,501	4,775	4,971	4,798	5,046	5,226	4,498	4,210	5,078
YOY Sales Growth %		12.37%	12.36%	3.67%	4.23%	2.36%	13.46%	18.86%	12.11%	9.44%	-9.51%	-12.25%	0.62%
	3,114	3,286	3,025	3,209	3,141	3,337	3,309	3,479	3,422	3,703	3,777	3,643	3,992
Material Cost %	34%	33%	31%	29%	29%	30%	28%	29%	28%	30%	36%	33%	34%
Employee Cost %	15%	15%	15%	16%	17%	16%	15%	16%	16%	16%	18%	21%	18%
Other Expenses %	23%	23%	23%	34%	24%	25%	24%	27%	23%	25%	30%	33%	27%
Operating Profit	1,205	1,379	1,356	828	1,360	1,438	1,662	1,319	1,624	1,523	721	567	1,086
OPM %	28%	30%	31%	21%	30%	30%	33%	27%	32%	29%	16%	13%	21%
	158	205	169	539	214	289	189	293	271	255	417	180	243
Exceptional items								295			-244
Interest	0	8	9	5	5	3	4	3	6	3	4	7	6
Depreciation	136	180	135	137	138	146	143	148	146	141	153	218	169
Profit before tax	1,226	1,397	1,381	1,224	1,430	1,578	1,704	1,756	1,744	1,633	736	522	1,154
	27%	26%	26%	20%	26%	25%	16%	15%	25%	26%	16%	26%	25%
Current tax	340	368	349	240	358	407	263	333	456	412	114	120	308
Deferred tax	-9	-1	14	2	17	-6	3	-63	-15	11	5	18	-16
	895	1,030	1,114	1,038	1,056	1,178	1,438	1,485	1,303	1,211	617	385	862
YOY Profit Growth %		42.95%	64.20%	192.10%	17.98%	14.42%	29.08%	43.05%	23.41%	2.75%	-57.11%	-74.11%	-33.84%
EPS in Rs	11.09	12.76	13.80	12.86	13.08	14.59	17.81	18.39	16.13	14.99	7.64	4.76	10.67
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	15,219	16,362	17,132	19,160	21,763	22,753	25,774	27,548	28,163	28,324
YOY Sales Growth %		7.51%	4.70%	11.84%	13.59%	4.55%	13.28%	6.88%	2.23%
	12,393	13,265	13,926	14,907	17,211	17,726	19,483	20,420	22,280	23,027
Material Cost %	36%	35%	35%	38%	39%	36%	34%	32%	34%	35%
Employee Cost %	18%	17%	18%	17%	16%	17%	17%	18%	19%	20%
Other Expenses %	28%	28%	29%	22%	24%	25%	25%	24%	26%	26%
Operating Profit	2,826	3,097	3,206	4,252	4,553	5,027	6,291	7,128	5,883	5,297
OPM %	19%	19%	19%	22%	21%	22%	24%	26%	21%	19%
	358	477	344	266	281	475	747	862	882	834
Exceptional items	-78				-182	-182	-195		-276	-276
Interest	114	168	197	161	106	110	90	62	54	57
Depreciation	1,323	1,326	1,175	1,068	1,052	1,172	1,051	1,107	1,211	1,263
Profit before tax	1,669	2,079	2,178	3,290	3,493	4,038	5,702	6,821	5,224	4,536
	15%	27%	29%	27%	27%	30%	27%	22%	26%	26%
Current tax	561	748	683	1,053	1,137	1,265	1,697	1,708	1,441
Deferred tax	-311	-178	-52	-164	-203	-62	-150	-179	-87
	1,417	1,492	1,500	2,389	2,547	2,833	4,154	5,269	3,862	3,356
Profit from associates	-3	-17	-47	-13	-13	-3	-2	-22	-8	-9
Minority share	6	-35	-47	-16	30	31	32	-3	-17	-15
Profit to shareholders	1,411	1,528	1,547	2,405	2,517	2,802	4,122	5,273	3,879	3,371
YOY Profit Growth %		5.36%	0.47%	59.28%	6.62%	11.24%	46.62%	26.85%	-26.71%
EPS in Rs	17.53	18.97	19.19	29.82	31.20	34.72	51.05	65.29	48.03	41.74
Dividend Payout %						14%	17%	20%	33%

Compounded Sales Growth

5 Years:: 8%
3 Years:: 7%
TTM:: 2%

Compounded Profit Growth

5 Years:: 10%
3 Years:: 11%
TTM:: -38%

Stock Price CAGR

5 Years:: 8%
3 Years:: 4%
1 Year:: -16%

Return on Equity

4 Years:: 15%
Last Year:: 12%

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	11,445	12,374	12,659	13,901	13,092	15,791	16,574	19,045	18,980	19,011
YOY Sales Growth %		8.12%	2.30%	9.81%	-5.82%	20.61%	4.96%	14.91%	-0.34%
	9,249	9,872	9,952	10,179	9,725	11,998	12,090	13,266	14,545	15,115
Material Cost %	36%	36%	34%	37%	39%	36%	31%	29%	32%	33%
Employee Cost %	16%	15%	15%	15%	13%	15%	16%	16%	18%	18%
Other Expenses %	29%	28%	29%	22%	22%	25%	26%	25%	27%	28%
Operating Profit	2,196	2,502	2,707	3,722	3,366	3,793	4,484	5,778	4,435	3,897
OPM %	19%	20%	21%	27%	26%	24%	27%	30%	23%	20%
	335	578	893	230	667	457	1,071	985	1,123	1,094
Exceptional items	-78					-186		295	-244	-244
Interest	12	17	36	45	27	27	20	15	19	19
Depreciation	530	570	600	556	460	596	588	574	658	682
Profit before tax	1,911	2,493	2,964	3,351	3,546	3,441	4,947	6,469	4,636	4,046
	23%	24%	22%	26%	24%	28%	25%	20%	24%	24%
Current tax	431	576	546	904	887	1,011	1,227	1,360	1,102
Deferred tax	12	28	100	-22	-30	-40	6	-49	19
	1,469	1,888	2,318	2,468	2,958	2,513	4,077	5,158	3,515	3,074
YOY Profit Growth %		28.59%	22.76%	6.48%	19.84%	-15.03%	62.22%	26.50%	-31.85%
EPS in Rs	18.25	23.45	28.76	30.61	36.67	31.15	50.51	63.87	43.52	38.06
Dividend Payout %						16%	17%	20%	37%

Compounded Sales Growth

5 Years:: 6%
3 Years:: 6%
TTM:: -3%

Compounded Profit Growth

5 Years:: 7%
3 Years:: 12%
TTM:: -43%

Stock Price CAGR

5 Years:: 8%
3 Years:: 4%
1 Year:: -16%

Return on Equity

4 Years:: 15%
Last Year:: 12%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	161	161	162	162
Reserves	23,246	26,545	31,032	34,270
	803	559	438	614
Long term borrowings			12	117
Short term borrowings	520	247	80	141
	5,252	5,452	5,755	7,450
Trade payables	2,535	2,474	2,837	3,230
Minority interest	306	96	96	88
Current liabilities	5,110	5,246	5,484	7,014
Total Liabilities	29,463	32,718	37,387	42,496
	5,883	6,171	6,705	7,983
Gross block	10,467	11,025	12,153	14,163
Accumulated depreciation	4,585	4,854	5,448	6,180
Goodwill & intangibles	4,514	4,713	4,986	6,851
CWIP	892	1,102	1,443	1,943
	22,689	25,445	29,238	32,570
Inventories	5,156	5,238	5,642	6,597
Trade receivables	4,057	4,771	5,506	5,620
Cash & equivalents	628	640	589	1,018
Current assets	17,275	19,441	23,289	24,147
Total Assets	29,463	32,718	37,387	42,496

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3,238	4,134	5,005	3,940
Profit for the year	2,802	4,122	5,273	3,879
Working capital changes	-559	-806	-665	-225
Direct taxes paid	-1,302	-1,597	-1,668	-1,586
	-2,389	-2,988	-3,691	-2,326
Fixed assets purchased	-1,183	-1,349	-1,548	-3,079
Fixed assets sold	29	34	25	24
Investments purchased	-1,351	-1,697	-2,200	-17
Investments sold		1		573
	-958	-1,200	-1,293	-1,234
Proceeds from borrowings			12	188
Repayment of borrowings	-352	-300	-98
Interest paid	-65	-65	-36	-37
Dividends paid	-404	-686	-1,050	-1,292
Net Cash Flow	-109	-55	21	380
Free Cash Flow	2,055	2,785	3,457	861

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	12.0%	16.4%	18.2%	11.8%
ROCE	—	17.0%	21.0%	21.5%	14.9%
Operating margin	—	17.9%	21.1%	22.6%	17.5%
Net margin	—	12.5%	16.2%	19.4%	14.0%
Debt / equity	—	0.03	0.02	0.01	0.02
Current ratio	—	3.38	3.71	4.25	3.44
Debtor days	—	66	68	74	74
Inventory days	—	210	199	211	230
Days payable	—	103	94	106	113
Cash conversion cycle	—	173	173	179	191
Working capital days	—	198	204	239	226

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 29.21%
FIIs 20.21%
DIIs 34.63%
Public 15.94%

%	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	33.47%	33.47%	33.47%	30.91%	30.92%	29.19%	29.20%	29.19%	29.21%	29.21%	29.21%	29.21%
	25.74%	25.73%	25.83%	27.81%	28.80%	26.65%	26.28%	25.25%	24.55%	23.93%	22.56%	20.21%
Foreign portfolio investors (Cat. I)	25.20%	25.18%	25.26%	27.05%	27.98%	25.73%	25.46%	24.48%	23.79%	23.18%	21.84%	19.61%
Foreign portfolio investors (Cat. II)	0.54%	0.55%	0.56%	0.77%	0.82%	0.92%	0.82%	0.76%	0.75%	0.75%	0.71%	0.59%
	24.18%	24.33%	24.42%	24.95%	24.16%	27.71%	28.15%	29.26%	30.25%	30.72%	31.97%	34.63%
Mutual funds	16.48%	16.66%	16.83%	17.62%	17.48%	20.46%	20.51%	20.44%	20.23%	19.21%	18.66%	20.56%
Insurance companies	5.25%	5.34%	5.44%	5.18%	4.67%	5.10%	5.79%	6.81%	8.19%	9.55%	11.24%	11.76%
Banks	0.04%	0.13%	0.05%	0.10%	0.12%	0.19%	0.20%	0.10%	0.08%	0.07%	0.05%	0.10%
Provident & pension funds	1.91%	1.73%	1.66%	1.58%	1.41%	1.45%	1.15%	1.41%	1.35%	1.51%	1.69%	1.71%
Alternative investment funds	0.22%	0.19%	0.17%	0.18%	0.19%	0.21%	0.23%	0.21%	0.12%	0.10%	0.06%	0.21%
	16.60%	16.46%	16.28%	16.33%	16.11%	16.44%	16.37%	16.30%	15.99%	16.13%	16.25%	15.94%
Retail (up to ₹2 lakh)	6.55%	6.49%	6.42%	6.47%	6.45%	6.83%	6.79%	6.79%	6.63%	6.78%	7.00%	6.85%
HNIs (above ₹2 lakh)	7.90%	7.84%	7.78%	7.77%	7.71%	7.46%	7.34%	7.30%	7.20%	7.06%	6.98%	6.88%
NRIs	0.88%	0.88%	0.88%	0.88%	0.86%	0.99%	1.07%	1.05%	1.05%	1.14%	1.15%	1.17%
Bodies corporate	0.58%	0.54%	0.48%	0.50%	0.48%	0.54%	0.56%	0.55%	0.53%	0.55%	0.52%	0.46%
IEPF	0.32%	0.33%	0.33%	0.33%	0.33%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.31%
No. of Shareholders	4,26,863	4,25,731	4,36,154	4,63,569	4,70,234	5,25,114	5,43,420	5,49,655	5,34,587	5,40,521	5,84,217	5,78,679

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Cipla

Holder (above 1%)	Stake
Lici Ulip-Growth FundInsurance	9.75%
HDFC Flexi Cap FundMutual fund	4.48%
SBI NIFTY 50 EQUAL WEIGHT INDEX FUNDMutual fund · see the fund house	3.24%
ICICI Prudential Equity Savings FundMutual fund	2.36%
Nippon Life India Trustee Ltd-A/C Nippon India ArbMutual fund	1.96%
DSP Nifty 50 Index FundMutual fund	1.90%
Parag Parikh Arbitrage FundMutual fund	1.87%
Nps Trust A/C - Lic Pension Fund - Ups - Cg SchemPension fund	1.71%

As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 20.56% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Results announced: 27 Oct 2026
Ex-dividend date: 5 Jun 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Cipla Limited

What is the share price of Cipla Limited today?

Cipla Limited (CIPLA) last traded at ₹1,325.10 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Cipla Limited?

About ₹1,07,051 crore at the latest price.

What is the P/E ratio of Cipla Limited?

About 31.8 times its earnings over the last 12 months.

Is Cipla Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Cipla Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Cipla Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Cipla Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding Cipla

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Cipla Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next